Drugs / Peginterferon lambda alfa-1a
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04344600 | Jun 2020 → Sep 2021 | COVID-19 | Johns Hopkins University | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peginterferon lambda alfa-1a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04344600 ↗ |
| Route | Subcutaneous | “by subcutaneous injection” NCT04344600 ↗ |